Nektar to Announce Third Quarter 2007 Financial Results on Wednesday, November 7, 2007, After the Close of U.S. Financi...( SAN CARLOS Calif. Oct. 31 /- Nekt...),Health
Navigation Links
Nektar to Announce Third Quarter 2007 Financial Results on Wednesday, November 7, 2007, After the Close of U.S. Financial Markets
Date:10/31/2007
SAN CARLOS, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2007 on Wednesday, November 7, 2007, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call for analysts and investors beginning at 5:00 p.m. Eastern Time (ET).
Investors can access the press release and a live audio-only Webcast of the conference call through a link that is posted on the Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through November 21, 2007.
To access the conference call, follow these instructions:
Dial: (800) 299-6183 (U.S.); (617) 801-9713 (international)
Passcode: 21153437 (Howard Robin is the host)
An audio replay will be available shortly following the call through November 21, 2007 and can be accessed by dialing (888) 286-8010 (U.S.); or (617) 801-6888 (international) with a passcode of 86766898.
In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.
Nektar Therapeutics is a biopharmaceutical company that develops and
enables differentiated therapeutics with its industry-leading PEGylation
and pulmonary drug development platforms. Nektar PEGylation and pulmonary
technology, expertise, and manufacturing capabilities have enabled ten
approved products for part
'/>"/>
| SOURCE Nektar Therapeutics Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. OHSU Researchers Announce New Discovery
2. PM announces a new health care order for India
3. Partnership Between Diabetes India And Elsevier Announced
4. US Politicians Urge Movie Moghuls To Add Anti-Smoking Announcements
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
(Date:1/8/2009)...RNewswire-USNewswire/ -- A proposal by the State o...s Children,s Home has prompted the 125,000-member ...s annual Mid-Winter conference January 10-12, 2009... nearly unanimous opposition to the proposal. , ...50,000 in direct and in-kind support to the home, ...
(Date:1/8/2009)...PRNewswire/ -- The physicians of Northern Lake Med...n three northern Illinois,communities, announced ...e . , (Photo: http://www.newscom.com/cgi-b...nal medicine physicians serve patients through cli...ndenhurst and Fox Lake. , "The Northern Lak...
(Date:1/8/2009)... A congressionally manda...cal equipment -- already the slowest-rising cost i...ll only succeed in reducing the quality of, and ac... elsewhere in Medicare. Washington Post columni...erlooks the inherent flaws in the bidding program,...
(Date:1/8/2009)...Jan. 8 Many companies are starting...e economic environment. More than,ever will your ...manage its,biggest asset -- customers. To excel i...ters must master many fronts: creating effective c...agement, applying savvy market,segmentation, usin...
Breaking Medicine News(10 mins):Health News:Northern Lake Medical to Join Aurora Health Care 2Health News:Northern Lake Medical to Join Aurora Health Care 3Health News:George Will Column Misguided in Touting 'Competitive Bidding' as a Medicare Solution; Controversial Bidding Program is Actually Anti-Competitive and Lowers Quality of Care and Access to Care for Seniors and Disabled 2Health News:George Will Column Misguided in Touting 'Competitive Bidding' as a Medicare Solution; Controversial Bidding Program is Actually Anti-Competitive and Lowers Quality of Care and Access to Care for Seniors and Disabled 3Health News:George Will Column Misguided in Touting 'Competitive Bidding' as a Medicare Solution; Controversial Bidding Program is Actually Anti-Competitive and Lowers Quality of Care and Access to Care for Seniors and Disabled 4Health News:Marketers Share Customer-Centric Strategies for an Uncertain 2009 Economy, Feb 2-4 2[0] Indiana American Legion to Organize, Launch Opposition to Closing of Children's Home[0] Northern Lake Medical to Join Aurora Health Care[0] George Will Column Misguided in Touting 'Competitive Bidding' as a Medicare Solution; Controversial Bidding Program is Actually Anti-Competitive and Lowers Quality of Care and Access to Care for Seniors and Disabled[0] Marketers Share Customer-Centric Strategies for an Uncertain 2009 Economy, Feb 2-4
... with a low potassium intake are one and half time...has suggested that reduced quantities of potassium...e. //The focus on potassium is, perhaps, a new one...or salt intake low to avoid stroke. But sodium and...
...etish in day to day life. Keeping fit costs hardly...ities. If you belong to a gym or health club,// yo...liptical trainers, treadmill and stairmasters. Th...llars and might be beyond one's means, if you're w...
...leased into the blood after a meal, restrain the a...ive in treating obesity. The reason for feeling fu...rmone called PYY3-36 //which acts on the brain to ...erial College, London, now report on the first hum...
...ues with lasers help remove lines and wrinkled fro...ou're younger can take its toll in later years in ...in. But, says Dr Arielle Kauvar, a dermatologist a...eatment can readily achieve a smoother, firmer app...
Other Medicine News:(Date:1/8/2009)...n. 8 If you are taking prescriptio...t alone. Half of the people taking,prescription m...re,varied -- they forget, are busy with other pri...compliance has been called the Achilles heel of mo...t Koop commented, "Drugs don,t,work in people who...
(Date:1/7/2009)...fants Drive the Increase , , WHITE PLAINS, N.Y.... statistics confirm that the decades-long rise in ...tting more infants than ever at increased risk of ...es. , , Nearly 543,000 babies were born too soo...alth Statistics, which today released "Births: Fin...
(Date:1/6/2009)... on Successful Results from prior U.S., U.K. and C...-- Vital Therapies, Inc. (VTI), a development stag... patient enrollment has begun for a randomized, co...t will study the Extracorporeal Liver Assist Devic...ver Failure (ALF) under three protocols. The study...
(Date:1/6/2009)...., Jan. 6 Cequent Pharmaceuticals,... deliver RNAi-based treatments to prevent and trea...cently completed a successful toxicology study of ...NAi therapeutic targeting the primary oncogene (be...olyposis). FAP is an inherited gastrointestinal di...
Breaking Medicine Technology:Good Medicine: Smarter Smartphones for People With Chronic Disease 2Preterm Births Rise 36 Percent Since Early 1980s 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Customized treatments for sepsis lower treatment time and reduce length of ICU stays 13098 1Customized treatments for sepsis lower treatment time and reduce length of ICU stays 13098 2Abraham Lincoln Presenter to Speak in Tulsa This Saturday 13094 1Poll Shows Strong Doubts About Effectiveness of Federal Employment Verification System 2352 1Poll Shows Strong Doubts About Effectiveness of Federal Employment Verification System 2352 2AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 1AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 2AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 3AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 4AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 5AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 6AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 7AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 8AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 9AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 10AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 11[0] Good Medicine: Smarter Smartphones for People With Chronic Disease[1] Preterm Births Rise 36 Percent Since Early 1980s[0] ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers[2] Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
..., N.J.--(BUSINESS WIRE)--Jun 6, 2007 - Savient,Pha...that two,abstracts exploring Phase 2 Puricase(R) (...-failure gout patients will be,presented at the Eu...al Congress taking place June 13 - 16th in Barcelo...cine urate oxidase currently,in Phase 3 developmen...
...SINESS WIRE)--Jun 7, 2007 - Inovio Biomedical,Corp...DNA vaccines,for cancers and infectious diseases a...ed cancers, announced today that the,company,s par...im,safety and tolerability data on 18 subjects fro... electroporation technology for,intratumoral deliv...
Other Medicine Technology:Savient Pharmaceuticals Announces Acceptance of Two Gout-Related,Abstracts for Poster Presentation at the European League Against,Rheumatism (EULAR) 2007 Annual Congress 2Savient Pharmaceuticals Announces Acceptance of Two Gout-Related,Abstracts for Poster Presentation at the European League Against,Rheumatism (EULAR) 2007 Annual Congress 3Savient Pharmaceuticals Announces Acceptance of Two Gout-Related,Abstracts for Poster Presentation at the European League Against,Rheumatism (EULAR) 2007 Annual Congress 4Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 2Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 3Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 4Vical Interim Clinical Results Demonstrate Safety and Tolerability,of Inovio Biomedical's Electroporation DNA Delivery Technology 5...sician to isolate a treatment region, infuse a phy...means of oscillation of a Dispersion Wire. The Tre...ant balloons near the distal end and infusion hole...he compliant balloons isolate a treatment zone to ...
ACRYSOF® Posterior Chamber Intraocular Lenses are indicated for the replacement of the human lens to achieve visual correction of aphakia in patients sixty years and older. These lenses are inten
Single-Piece PMMA Intraocular Lenses.
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |